Gut microbes on the risk of advanced adenomas
More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina Hi...
Saved in:
Published in | BMC microbiology Vol. 24; no. 1; pp. 264 - 14 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.07.2024
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC.
To analyze the characteristic microbes in AA.
Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed.
The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively.
Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. |
---|---|
AbstractList | Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. Objective To analyze the characteristic microbes in AA. Methods Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze [alpha] diversity and [beta] diversity. [alpha] diversity included box diagram, and [beta] diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. Results The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Conclusion Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. Keywords: Advanced adenomas, Gut bacteria, Enteroviruses, Metagenomic sequencing, Prediction model More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze [alpha] diversity and [beta] diversity. [alpha] diversity included box diagram, and [beta] diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. Abstract Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. Objective To analyze the characteristic microbes in AA. Methods Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. Results The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Conclusion Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC.BACKGROUNDMore than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC.To analyze the characteristic microbes in AA.OBJECTIVETo analyze the characteristic microbes in AA.Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed.METHODSFecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed.The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively.RESULTSThe abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively.Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing.CONCLUSIONPrevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. The bacteria (including Prevotella sp900557255 , Alistipes putredinis , Megamonas funiformis , etc. ) and viruses (including Lilyvirus , Felixounavirus , and Drulisvirus , etc.) existed differences in AA. And there were correlations between AA and basic information, lipid index and serological index. Prediction models based on bacteria and viruses were established to distinguish AA, and the accuracy reached 87.27% and 83.33%. A new typing method was established based on bacteria and viruses to divide gut microbes into 4 subtypes. Prediction models after typing had higher accuracy (100% in B1V1, 96.34% in B1V2, 100% in B2V1, 98.46% in B2V2). The bacteria (including Prevotella sp900557255, Alistipes putredinis, Megamonas funiformis, etc.) and viruses (including Lilyvirus, Felixounavirus, and Drulisvirus, etc.) existed differences in AA. And there were correlations between AA and basic information, lipid index and serological index.Prediction models based on bacteria and viruses were established to distinguish AA, and the accuracy reached 87.27% and 83.33%.A new typing method was established based on bacteria and viruses to divide gut microbes into 4 subtypes.Prediction models after typing had higher accuracy (100% in B1V1, 96.34% in B1V2, 100% in B2V1, 98.46% in B2V2). More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both AA and CRC. To analyze the characteristic microbes in AA. Fecal samples were collected from 92 AA and 184 negative control (NC). Illumina HiSeq X sequencing platform was used for high-throughput sequencing of microbial populations. The sequencing results were annotated and compared with NCBI RefSeq database to find the microbial characteristics of AA. R-vegan package was used to analyze α diversity and β diversity. α diversity included box diagram, and β diversity included Principal Component Analysis (PCA), principal co-ordinates analysis (PCoA), and non-metric multidimensional scaling (NMDS). The AA risk prediction models were constructed based on six kinds of machine learning algorithms. In addition, unsupervised clustering methods were used to classify bacteria and viruses. Finally, the characteristics of bacteria and viruses in different subtypes were analyzed. The abundance of Prevotella sp900557255, Alistipes putredinis, and Megamonas funiformis were higher in AA, while the abundance of Lilyvirus, Felixounavirus, and Drulisvirus were also higher in AA. The Catboost based model for predicting the risk of AA has the highest accuracy (bacteria test set: 87.27%; virus test set: 83.33%). In addition, 4 subtypes (B1V1, B1V2, B2V1, and B2V2) were distinguished based on the abundance of gut bacteria and enteroviruses (EVs). Escherichia coli D, Prevotella sp900557255, CAG-180 sp000432435, Phocaeicola plebeiuA, Teseptimavirus, Svunavirus, Felixounavirus, and Jiaodavirus are the characteristic bacteria and viruses of 4 subtypes. The results of Catboost model indicated that the accuracy of prediction improved after incorporating subtypes. The accuracy of discovery sets was 100%, 96.34%, 100%, and 98.46% in 4 subtypes, respectively. Prevotella sp900557255 and Felixounavirus have high value in early warning of AA. As promising non-invasive biomarkers, gut microbes can become potential diagnostic targets for AA, and the accuracy of predicting AA can be improved by typing. |
ArticleNumber | 264 |
Audience | Academic |
Author | Xinyue, Wu Zheng, Wu Jing, Zhuang Feimin, Zhao Hong, Shen Shuwen, Han Qiang, Wei Xiaojian, Yu Jianwen, Song Yunfeng, Yin |
Author_xml | – sequence: 1 givenname: Zhuang surname: Jing fullname: Jing, Zhuang – sequence: 2 givenname: Wu surname: Zheng fullname: Zheng, Wu – sequence: 3 givenname: Song surname: Jianwen fullname: Jianwen, Song – sequence: 4 givenname: Shen surname: Hong fullname: Hong, Shen – sequence: 5 givenname: Yu surname: Xiaojian fullname: Xiaojian, Yu – sequence: 6 givenname: Wei surname: Qiang fullname: Qiang, Wei – sequence: 7 givenname: Yin surname: Yunfeng fullname: Yunfeng, Yin – sequence: 8 givenname: Wu surname: Xinyue fullname: Xinyue, Wu – sequence: 9 givenname: Han surname: Shuwen fullname: Shuwen, Han – sequence: 10 givenname: Zhao surname: Feimin fullname: Feimin, Zhao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39026166$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhS1URB_wB1igSGzKIsV2Ej9WqKqgjFQJicfachx76iGxi-1U0F_PTaeUToWQF7auv3OufH0O0V6IwSL0kuATQgR7mwkVjNWYtjVuWsLqmyfogLSc1JQIvPfgvI8Oc95gTLho-DO030hMGWHsANXnc6kmb1Lsba5iqMqlrZLP36voKj1c62DsAAcb4qTzc_TU6THbF3f7Efr24f3Xs4_1xafz1dnpRW06KUrNtezFYEzvrIBWHWat67jjTLiOYahLw11POyOcNQBoKS21ncPCEagPzRFabX2HqDfqKvlJp18qaq9uCzGtlU7Fm9EqJ1vO4C39IGzbD1w2uDVacyFF2zFCwOvd1utq7ic7GBtK0uOO6e5N8JdqHa8VIbRjjVwcju8cUvwx21zU5LOx46iDjXNWDRaUUc75gr5-hG7inALMCihJqKSyFX-ptYYX-OAiNDaLqToVmAjRNC0F6uQfFKzBwodBFJyH-o7gzY4AmGJ_lrWec1arL5932VcPp3I_jj_JAIBuAYhGzsm6e4RgtcRPbeOnIH7qNn7qBkTikcj4oouPy2T9-D_pb76P2xw |
CitedBy_id | crossref_primary_10_1186_s42523_025_00378_z crossref_primary_10_1016_j_apsoil_2024_105663 crossref_primary_10_3390_biomedicines13010009 |
Cites_doi | 10.1038/s41564-019-0551-1 10.1038/s41591-019-0458-7 10.3390/antibiotics10070806 10.1136/bmj.n877 10.1016/j.tim.2018.09.006 10.1186/s12866-022-02712-w 10.1038/s41591-018-0308-z 10.3390/microorganisms10030664 10.1016/j.gtc.2018.04.004 10.1172/JCI155101 10.1128/mBio.01143-21 10.1038/s41579-021-00559-y 10.3748/wjg.v28.i30.4053 10.1186/gb-2011-12-6-r60 10.1053/j.gastro.2023.03.208 10.1093/cid/cix881 10.1093/advances/nmaa104 10.3748/wjg.v24.i1.5 10.1128/spectrum.01593-22 10.3389/fimmu.2020.615056 10.1177/1756284819836620 10.4161/gmic.1.3.12360 10.1007/s12094-022-03061-w 10.1080/19490976.2021.1949096 10.3389/fimmu.2022.921546 10.1016/S2213-2600(19)30397-2 10.3390/v11070656 10.1002/cam4.3289 10.1016/S2468-1253(18)30282-6 10.1126/sciimmunol.abn6660 10.12968/jowc.2018.27.Sup4.S24 10.1038/nrmicro1656 10.1053/j.gastro.2018.08.063 10.1128/AEM.02627-17 10.3322/caac.21660 10.1038/s41598-020-73902-7 10.1016/j.ccell.2018.03.004 10.3389/fmicb.2018.02200 10.1038/s41588-022-01088-x 10.1038/ajg.2017.360 10.1186/gb-2014-15-3-r46 10.1016/j.semcancer.2021.10.004 10.3389/fcimb.2022.1054808 10.1183/13993003.02881-2020 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QL 7T7 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12866-024-03416-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database Proquest Central Journals Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts Proquest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Proquest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1471-2180 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_f9476616bd8e4bd79304caa789845611 PMC11256391 A801883342 39026166 10_1186_s12866_024_03416_z |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: PublicWelfare Technology Application Research Program of Huzhou grantid: No. 2023GY18 – fundername: Zhejiang Medical and Health Technology Project grantid: No.2023KY1178 – fundername: China University Industry University Research Innovation Fund grantid: No.2023HT078 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LK5 LK8 M1P M48 M7P M7R MM. M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB ~02 -A0 3V. ACRMQ ADINQ AGJBV C24 CGR CUY CVF ECM EIF NPM PMFND 7QL 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c598t-7a9b8dccbfe83905064f57f768f560ccb9c7fb25c8fec390a99e2e5f08f1fb2d3 |
IEDL.DBID | M48 |
ISSN | 1471-2180 |
IngestDate | Wed Aug 27 01:23:35 EDT 2025 Thu Aug 21 18:33:04 EDT 2025 Fri Jul 11 09:38:15 EDT 2025 Fri Jul 25 10:52:38 EDT 2025 Tue Jun 17 22:09:57 EDT 2025 Tue Jun 10 21:07:33 EDT 2025 Fri Jun 27 05:37:33 EDT 2025 Wed Feb 19 02:07:42 EST 2025 Tue Jul 01 04:31:46 EDT 2025 Thu Apr 24 22:58:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Enteroviruses Gut bacteria Advanced adenomas Prediction model Metagenomic sequencing |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c598t-7a9b8dccbfe83905064f57f768f560ccb9c7fb25c8fec390a99e2e5f08f1fb2d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3091292948?pq-origsite=%requestingapplication% |
PMID | 39026166 |
PQID | 3091292948 |
PQPubID | 42585 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f9476616bd8e4bd79304caa789845611 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11256391 proquest_miscellaneous_3082627771 proquest_journals_3091292948 gale_infotracmisc_A801883342 gale_infotracacademiconefile_A801883342 gale_incontextgauss_ISR_A801883342 pubmed_primary_39026166 crossref_primary_10_1186_s12866_024_03416_z crossref_citationtrail_10_1186_s12866_024_03416_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-07-18 |
PublicationDateYYYYMMDD | 2024-07-18 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC microbiology |
PublicationTitleAlternate | BMC Microbiol |
PublicationYear | 2024 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | C Dubé (3416_CR4) 2017; 112 B Liu (3416_CR12) 2022; 13 A Adibi (3416_CR43) 2020; 8 N Segata (3416_CR26) 2011; 12 WR Becker (3416_CR30) 2022; 54 Z Qi (3416_CR44) 2022; 22 A Piantadosi (3416_CR23) 2021; 12 M Song (3416_CR6) 2021; 373 W Yinhang (3416_CR29) 2023; 25 OF Ahmad (3416_CR7) 2019; 4 AEV Quaglio (3416_CR13) 2022; 28 AF Peery (3416_CR3) 2019; 156 ZH Shen (3416_CR9) 2018; 24 A Tett (3416_CR33) 2021; 19 XJ Shen (3416_CR31) 2010; 1 B Yilmaz (3416_CR10) 2019; 25 3416_CR35 3416_CR14 3416_CR36 PJ Simner (3416_CR22) 2018; 66 MU Ijaz (3416_CR27) 2018; 9 I Mukhopadhya (3416_CR37) 2019; 12 3416_CR38 H Tilg (3416_CR8) 2018; 33 S Han (3416_CR24) 2022; 10 J Diep (3416_CR16) 2019; 4 H Sung (3416_CR1) 2021; 71 HH Zhao-Fleming (3416_CR34) 2018; 27 F Adiliaghdam (3416_CR20) 2022; 7 V Sintchenko (3416_CR39) 2007; 5 Y Zhao (3416_CR19) 2021; 12 P Zéboulon (3416_CR41) 2020; 10 S Yachida (3416_CR21) 2019; 25 PJ Pickhardt (3416_CR5) 2018; 47 Z Wang (3416_CR17) 2022; 86 DE Wood (3416_CR25) 2014; 15 3416_CR40 Y Cheng (3416_CR15) 2020; 11 3416_CR42 JM Bech (3416_CR2) 2023; 165 S Kilcher (3416_CR18) 2019; 27 E Caparrós (3416_CR11) 2021; 13 3416_CR28 X Zhong (3416_CR32) 2022; 12 |
References_xml | – volume: 4 start-page: 2523 issue: 12 year: 2019 ident: 3416_CR16 publication-title: Nat Microbiol doi: 10.1038/s41564-019-0551-1 – volume: 25 start-page: 968 issue: 6 year: 2019 ident: 3416_CR21 publication-title: Nat Med doi: 10.1038/s41591-019-0458-7 – ident: 3416_CR38 doi: 10.3390/antibiotics10070806 – volume: 373 start-page: n877 year: 2021 ident: 3416_CR6 publication-title: BMJ doi: 10.1136/bmj.n877 – volume: 27 start-page: 355 issue: 4 year: 2019 ident: 3416_CR18 publication-title: Trends Microbiol doi: 10.1016/j.tim.2018.09.006 – volume: 22 start-page: 312 issue: 1 year: 2022 ident: 3416_CR44 publication-title: BMC Microbiol doi: 10.1186/s12866-022-02712-w – volume: 25 start-page: 323 issue: 2 year: 2019 ident: 3416_CR10 publication-title: Nat Med doi: 10.1038/s41591-018-0308-z – ident: 3416_CR40 doi: 10.3390/microorganisms10030664 – volume: 47 start-page: 515 issue: 3 year: 2018 ident: 3416_CR5 publication-title: Gastroenterol Clin North Am doi: 10.1016/j.gtc.2018.04.004 – ident: 3416_CR14 doi: 10.1172/JCI155101 – volume: 12 start-page: e0114321 issue: 4 year: 2021 ident: 3416_CR23 publication-title: mBio doi: 10.1128/mBio.01143-21 – volume: 19 start-page: 585 issue: 9 year: 2021 ident: 3416_CR33 publication-title: Nat Rev Microbiol doi: 10.1038/s41579-021-00559-y – volume: 28 start-page: 4053 issue: 30 year: 2022 ident: 3416_CR13 publication-title: World J Gastroenterol doi: 10.3748/wjg.v28.i30.4053 – volume: 12 start-page: R60 issue: 6 year: 2011 ident: 3416_CR26 publication-title: Genome Biol doi: 10.1186/gb-2011-12-6-r60 – volume: 165 start-page: 121 issue: 1 year: 2023 ident: 3416_CR2 publication-title: Gastroenterology doi: 10.1053/j.gastro.2023.03.208 – volume: 66 start-page: 778 issue: 5 year: 2018 ident: 3416_CR22 publication-title: Clin Infect Dis doi: 10.1093/cid/cix881 – volume: 12 start-page: 546 issue: 2 year: 2021 ident: 3416_CR19 publication-title: Adv Nutr doi: 10.1093/advances/nmaa104 – volume: 24 start-page: 5 issue: 1 year: 2018 ident: 3416_CR9 publication-title: World J Gastroenterol doi: 10.3748/wjg.v24.i1.5 – volume: 10 start-page: e0159322 issue: 6 year: 2022 ident: 3416_CR24 publication-title: Microbiol Spectr doi: 10.1128/spectrum.01593-22 – volume: 11 start-page: 615056 year: 2020 ident: 3416_CR15 publication-title: Front Immunol doi: 10.3389/fimmu.2020.615056 – volume: 12 start-page: 175628481983662 year: 2019 ident: 3416_CR37 publication-title: Th Adv Gastroenterol doi: 10.1177/1756284819836620 – volume: 1 start-page: 138 issue: 3 year: 2010 ident: 3416_CR31 publication-title: Gut Microbes doi: 10.4161/gmic.1.3.12360 – volume: 25 start-page: 1661 issue: 6 year: 2023 ident: 3416_CR29 publication-title: Clin Transl Oncol doi: 10.1007/s12094-022-03061-w – volume: 13 start-page: 1949096 issue: 1 year: 2021 ident: 3416_CR11 publication-title: Gut Microbes doi: 10.1080/19490976.2021.1949096 – volume: 13 start-page: 921546 year: 2022 ident: 3416_CR12 publication-title: Front Immunol doi: 10.3389/fimmu.2022.921546 – volume: 8 start-page: 1013 issue: 10 year: 2020 ident: 3416_CR43 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(19)30397-2 – ident: 3416_CR35 doi: 10.3390/v11070656 – ident: 3416_CR28 doi: 10.1002/cam4.3289 – volume: 4 start-page: 71 issue: 1 year: 2019 ident: 3416_CR7 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(18)30282-6 – volume: 7 start-page: eabn6660 issue: 70 year: 2022 ident: 3416_CR20 publication-title: Sci Immunol doi: 10.1126/sciimmunol.abn6660 – volume: 27 start-page: S24 issue: Sup4 year: 2018 ident: 3416_CR34 publication-title: J Wound Care doi: 10.12968/jowc.2018.27.Sup4.S24 – volume: 5 start-page: 464 issue: 6 year: 2007 ident: 3416_CR39 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1656 – volume: 156 start-page: 254 issue: 1 year: 2019 ident: 3416_CR3 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.063 – ident: 3416_CR36 doi: 10.1128/AEM.02627-17 – volume: 71 start-page: 209 issue: 3 year: 2021 ident: 3416_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 10 start-page: 16973 issue: 1 year: 2020 ident: 3416_CR41 publication-title: Sci Rep doi: 10.1038/s41598-020-73902-7 – volume: 33 start-page: 954 issue: 6 year: 2018 ident: 3416_CR8 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.03.004 – volume: 9 start-page: 2200 year: 2018 ident: 3416_CR27 publication-title: Front Microbiol doi: 10.3389/fmicb.2018.02200 – volume: 54 start-page: 985 issue: 7 year: 2022 ident: 3416_CR30 publication-title: Nat Genet doi: 10.1038/s41588-022-01088-x – volume: 112 start-page: 1790 issue: 12 year: 2017 ident: 3416_CR4 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2017.360 – volume: 15 start-page: R46 issue: 3 year: 2014 ident: 3416_CR25 publication-title: Genome Biol doi: 10.1186/gb-2014-15-3-r46 – volume: 86 start-page: 943 issue: Pt 2 year: 2022 ident: 3416_CR17 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2021.10.004 – volume: 12 start-page: 1054808 year: 2022 ident: 3416_CR32 publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2022.1054808 – ident: 3416_CR42 doi: 10.1183/13993003.02881-2020 |
SSID | ssj0017837 |
Score | 2.4634664 |
Snippet | More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and progression of both... Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and... The bacteria (including Prevotella sp900557255, Alistipes putredinis, Megamonas funiformis, etc.) and viruses (including Lilyvirus, Felixounavirus, and... The bacteria (including Prevotella sp900557255 , Alistipes putredinis , Megamonas funiformis , etc. ) and viruses (including Lilyvirus , Felixounavirus , and... Abstract Background More than 90% of colorectal cancer (CRC) arises from advanced adenomas (AA) and gut microbes are closely associated with the initiation and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 264 |
SubjectTerms | Adenoma - microbiology Adenoma - virology Advanced adenomas Aged Algorithms Bacteria Bacteria - classification Bacteria - genetics Bacteria - isolation & purification Biological diversity Biomarkers Cancer Care and treatment Colonoscopy Colorectal cancer Colorectal Neoplasms - microbiology Colorectal Neoplasms - virology Comparative analysis Composition Data mining Diagnosis Enteroviruses Escherichia coli Feces Feces - microbiology Feces - virology Female Gastrointestinal Microbiome - genetics Genomes Gut bacteria High-Throughput Nucleotide Sequencing Homeostasis Hospitals Humans Inflammatory bowel disease Informed consent Irritable bowel syndrome Lipids Machine Learning Male Metagenomic sequencing Methods Microbiota (Symbiotic organisms) Microorganisms Middle Aged Patient compliance Patients Prediction model Prediction models Prevention Rectal polyps Risk factors Software Tumors Typing Veganism Viruses Viruses - classification Viruses - genetics Viruses - isolation & purification Viruses - pathogenicity |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEB9kQfAirp_VVaoIHiRsP_J5XMV19eBBXdhbSNJEBW3FvnfY_eudSdvHK4JevJVkAulvJpnf0OkMwHPVJY1-SLDURcmQgXPmTGUYcWvTeokkP2dbfJBn5_z9hbjYa_VFOWFTeeAJuONkuEIfIn2nI_cdmlPFg3NKG02-Pwc-6POWYGr-fqAw7lp-kdHyeMRbWFKyLWcVXtuSXa3cUK7W_-edvOeU1gmTex7o9BbcnKljeTJt-RCuxf42XJ-aSV7eAfZ2uyl_UH6dj2M59CVSu5Iyx8shlcunfnyIPaUE3YXz0zefX5-xuRkCC8LoDVPOeN2F4FNETlNRnbkkVMJoISFpwXETVPKNCDrFgALOmNhEkSqdahzv2ntw0A99fACl9LUT0aXUGgSjFk5w17St06JrRMtVAfWCjQ1zpXBqWPHd5ohBSzvhaRFPm_G0VwW83K35OdXJ-Kv0K4J8J0k1rvMAat7Omrf_0nwBz0hhlqpY9JQm88Vtx9G--_TRnqDfpS7KvCngxSyUBnyH4Oa_DhAJKny1kjxaSeIxC-vpxS7sfMxH26LlNUgwuS7g6W6aVlLqWh-HLclgBNcopXDD9ycz2r036gkjWCkL0CsDWwGznum_fc1FwJEnC2SX9cP_AeUjuNHkw6FYrY_gYPNrGx8j2dr4J_lc_QbWrSGN priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9YwDI5gCInLxDdlAxWExAFF60c-T2ggxuDAAZj03qI0TbZJo93W9z2wXz87TcsqpN2qxJVax7Efp09tQt7JNiiIQ5yG1gsKCJxRqwtNEVvruhEA8iPb4oc4PGLfV3yVDtyGRKucfGJ01G3v8Ix8r4bAVkEsZ-rj-QXFrlH4dTW10LhL7mHpMrRquZoTrlJC9jX9KKPE3gC-WCDlltECnLegV4tgFGv2_--Zb4SmJW3yRhw6eEi2E4DM98cVf0Tu-O4xuT-2lPz7hNCvm3X-B1l2jR_yvssB4OXIH8_7kE8f_OHCd0gMekqODr78_nxIU0sE6rhWayqtblTrXBM8IJsCq80FLgPkDAGgC4xrJ0NTcaeCdyBgtfaV56FQoYTxtn5Gtrq-8y9ILprScm9DqDUoo-SWM1vVtVW8rXjNZEbKSTfGpXrh2LbizMS8QQkz6tOAPk3Up7nKyIf5nvOxWsat0p9Q5bMkVrqOA_3lsUkbxwTNJGAI0bTKs6YFd1IwZ61UWiH2KzPyFhfMYC2LDskyx3YzDObbr59mH6Iv9lJmVUbeJ6HQwzs4m_49AE1g-auF5O5CEjabW05PdmHSZh_MP9PMyJt5Gu9EAlvn-w3KQB5XSSnhgZ-PZjS_N6wT5LFCZEQtDGyhmOVMd3oSS4EDWuaAMcuXtz_XDnlQRbOXtFS7ZGt9ufGvAEytm9dxx1wDMb8Z-Q priority: 102 providerName: ProQuest |
Title | Gut microbes on the risk of advanced adenomas |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39026166 https://www.proquest.com/docview/3091292948 https://www.proquest.com/docview/3082627771 https://pubmed.ncbi.nlm.nih.gov/PMC11256391 https://doaj.org/article/f9476616bd8e4bd79304caa789845611 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFD70guCLeG-0LlEEH2Q0l7k-iHSltQoWWV1YfBkmyUwVaqKbXbD99Z6ZJGuDpS_LMnOyJCfn8p3sl3MAnovKScxDjLjKcoIInBKjEkU8tlZ5wRHkB7bFCT-e048LttiCYdxRr8D2ytLOz5OaL89e_fl9_hYd_k1weMlftxhjuafSUpJgUObkYht2MTMJP9HgE_33r4KQoYdmigGZYGpLhpdorvyNUaIK_fz_j9qX0taYUnkpRx3dhls9uIwPOmu4A1u2vgs3unGT5_eAvF-v4p-egVfYNm7qGMFf7LnlcePigQyAX2ztSUP3YX50-PXdMenHJZCSKbkiwqhCVmVZOIuoJ_Gd6BwTDusJh7AG11UpXJGxUjpbooBRymaWuUS6FNer_AHs1E1t9yDmRWqYNc7lCpWRMsOoyfLcSFZlLKcignTQjS77XuJ-pMWZDjWF5LrTp0Z96qBPfRHBy80xv7pOGtdKT73KN5K-C3ZYaJanuncq7RQViC94UUlLiwpDTUJLY4RU0uPCNIJn_oZp3-ei9kSaU7NuW_3hy0wfYGb2c5ZpFsGLXsg1eA2l6d9LQE341lgjyf2RJDpiOd4e7EIPdqxzxGMZQlAqI3i62fZHenJbbZu1l8EaLxNC4Ak_7Mxoc914n7DG5TwCOTKwkWLGO_WP76FNOCJphvgzfXT9aT-Gm6nCcBmeLO3Dzmq5tk8QaK2KCWyLhZjA7vTw5PNsEh5XTIJH4eds-u0v-gIjdg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2gQEAgDshq4sSvA0LlUXZp6QFaaW-u49ilUklKsyvU_ih-IzN5LI2QeustsidRMp7x983ueIaQl7IMCnCI01B6QYGB59TqRFPk1jorBJD8NttiR0z28i8zPlshf4azMJhWOeyJ7UZd1g5_I1_PANgYYHmu3h3_otg1Cv9dHVpodGax5U9_Q8jWvJ1-hPV9xdjmp90PE9p3FaCOazWn0upClc4VwQM5SLBgW-AyAO0OgP4wrp0MBeNOBe9AwGrtmechUSGF8TKD514hVwF4Ewz25GwZ4KUSor3hYI4S6w3s_QJTfHOaAFgIejYCv7ZHwP9IcA4Kx2ma53Bv8xa52RPWeKOzsNtkxVd3yLWuheXpXUI_L-bxT8zqK3wT11UMhDLGfPW4DvGQYAAXvsJEpHtk71KUdZ-sVnXlH5JYFKnl3oaQaVBGyi3PLcsyq3jJeJbLiKSDbozr65Njm4wj08YpSphOnwb0aVp9mrOIvFnec9xV57hQ-j2qfCmJlbXbgfrkwPSOaoLOJXAWUZTK50UJ21eSO2ul0gq5ZhqRF7hgBmtnVJicc2AXTWOm37-ZDUB77N2cs4i87oVCDd_gbH_WATSB5bZGkmsjSXBuN54e7ML0m0tj_rlCRJ4vp_FOTJirfL1AGYgbmZQSXvhBZ0bL74Z1grhZiIiokYGNFDOeqQ5_tKXHgZ1z4LTpo4vf6xm5Ptn9um22pztbj8kN1rqApKlaI6vzk4V_AkRuXjxtvScm-5ftrn8BLLRY1A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+microbes+on+the+risk+of+advanced+adenomas&rft.jtitle=BMC+microbiology&rft.au=Jing%2C+Zhuang&rft.au=Zheng%2C+Wu&rft.au=Jianwen%2C+Song&rft.au=Hong%2C+Shen&rft.date=2024-07-18&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2180&rft.eissn=1471-2180&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12866-024-03416-z&rft.externalDocID=A801883342 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon |